CLINICAL_TRIALS ClinicalTrials.gov record update

Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00819910
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:43.342061+00:00
Published At: 2014-02-26T00:00:00+00:00
Record Updated At: 2014-04-24
Results Posted At: 2014-02-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hypertriglyceridemia in Type 4 Hyperlipidemia", "Non Diabetic Subjects With Normoglycemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-04-24"
protocolSection.identificationModule.nctId: "NCT00819910"
protocolSection.identificationModule.officialTitle: "Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-02-26"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.